AIMS: We aimed to assess the impact of B-type natriuretic peptide (BNP) on short-term outcomes in patients undergoing transcatheter aortic valve implantation (TAVI). METHODS AND RESULTS: Of 500 consecutive patients with severe aortic stenosis undergoing TAVI at our institution, we studied 340 patients who had a BNP assessment prior to TAVI. Patients were divided into tertiles - low: BNP ≤201 pg/mL (n=114), mid: BNP 202-595 pg/mL (n=113) and high: BNP ≥596 pg/mL (n=113). The primary endpoint was all-cause mortality, cardiac death and major adverse cardiac and cerebrovascular events (MACCE; death, major stroke and myocardial infarction) at 30 days. Compared with low tertile, high tertile patients were at higher baseline surgical risk (STS score 5.5±3.0 vs. 7.4±4.1, p=0.002). On echocardiography, high tertile patients had smaller valve areas (0.74±0.21 vs. 0.66±0.23 cm², p=0.008), higher left ventricular (LV) mass indices (123.40±33.66 vs. 168.22±47.96 g/m², p<0.001) and lower LV ejection fractions (61.59±7.18 vs. 42.65±15.41%, p<0.001) as compared with low tertile patients. At 30 days, a significantly higher incidence of death (hazard ratio [HR] 7.41, p=0.001) cardiac death (HR 5.82, p=0.006) and MACCE (HR 9.04, p<0.001) was observed among high as compared to low tertile patients. CONCLUSIONS: In TAVI patients, higher BNP values at baseline are associated with an increased risk for an adverse event periprocedurally and after 30 days, respectively.
AIMS: We aimed to assess the impact of B-type natriuretic peptide (BNP) on short-term outcomes in patients undergoing transcatheter aortic valve implantation (TAVI). METHODS AND RESULTS: Of 500 consecutive patients with severe aortic stenosis undergoing TAVI at our institution, we studied 340 patients who had a BNP assessment prior to TAVI. Patients were divided into tertiles - low: BNP ≤201 pg/mL (n=114), mid: BNP 202-595 pg/mL (n=113) and high: BNP ≥596 pg/mL (n=113). The primary endpoint was all-cause mortality, cardiac death and major adverse cardiac and cerebrovascular events (MACCE; death, major stroke and myocardial infarction) at 30 days. Compared with low tertile, high tertile patients were at higher baseline surgical risk (STS score 5.5±3.0 vs. 7.4±4.1, p=0.002). On echocardiography, high tertile patients had smaller valve areas (0.74±0.21 vs. 0.66±0.23 cm², p=0.008), higher left ventricular (LV) mass indices (123.40±33.66 vs. 168.22±47.96 g/m², p<0.001) and lower LV ejection fractions (61.59±7.18 vs. 42.65±15.41%, p<0.001) as compared with low tertile patients. At 30 days, a significantly higher incidence of death (hazard ratio [HR] 7.41, p=0.001) cardiac death (HR 5.82, p=0.006) and MACCE (HR 9.04, p<0.001) was observed among high as compared to low tertile patients. CONCLUSIONS: In TAVI patients, higher BNP values at baseline are associated with an increased risk for an adverse event periprocedurally and after 30 days, respectively.
Authors: Stanislav Keranov; Won-Keun Kim; Mani Arsalan; Matthias Renker; Till Keller; Timm Bauer; Oliver Dörr; Holger M Nef; Luise Gaede; Helge Möllmann; Thomas Walther; Christian W Hamm; Christoph Liebetrau Journal: Heart Vessels Date: 2019-06-07 Impact factor: 2.037
Authors: Hüseyin Ayhan; Hacı Ahmet Kasapkara; Tahir Durmaz; Telat Keleş; Cenk Sarı; Serdal Baştuğ; Kemal Eşref Erdoğan; Nihal Akar Bayram; Emine Bilen; Murat Akçay; Engin Bozkurt Journal: J Geriatr Cardiol Date: 2015-03 Impact factor: 3.327
Authors: Kimi Sato; Arnav Kumar; Amar Krishnaswamy; Stephanie Mick; Milind Y Desai; Brian P Griffin; Samir R Kapadia; Zoran B Popović Journal: Clin Cardiol Date: 2018-12-31 Impact factor: 2.882
Authors: Hatim Seoudy; Johanne Frank; Markus Neu; Nathalie Güßefeld; Yannic Klaus; Sandra Freitag-Wolf; Moritz Lambers; Georg Lutter; Astrid Dempfle; Ashraf Yusuf Rangrez; Christian Kuhn; Norbert Frey; Derk Frank Journal: J Am Heart Assoc Date: 2019-02-05 Impact factor: 5.501
Authors: Yukari Kobayashi; Juyong B Kim; Kegan J Moneghetti; Michael Fischbein; Anson Lee; Claire A Watkins; Alan C Yeung; David Liang; Mehmet O Ozen; Utkan Demirci; Raffick Bowen; William F Fearon; Francois Haddad Journal: Sci Rep Date: 2019-10-17 Impact factor: 4.379
Authors: Christopher J Allen; Jubin Joseph; Tiffany Patterson; Matthew Hammond-Haley; Hannah Z R McConkey; Bernard D Prendergast; Michael Marber; Simon R Redwood Journal: J Am Heart Assoc Date: 2020-11-26 Impact factor: 5.501
Authors: Heidi Lehtola; Jarkko Piuhola; Matti Niemelä; Tuomas Tauriainen; Juhani Junttila; Timo Mäkikallio; Tatu Juvonen; Fausto Biancari Journal: J Cardiovasc Med (Hagerstown) Date: 2022-01-01 Impact factor: 2.160